-
India's only sterile cephalosporins facility to receive approvals by the USFDA and
UKMCA
-
Asia's only USFDA-approved fermentation plant for
rifampicin
-
Successful USFDA certification for cefaclor, cefotaxime and 7-ACCA plants in first
attempt
-
Successful transfer of technology by Lupin's quality assurance cell, to evaluate the quality of sterile cephalosporins, to Merck in UK and
France
-
Among world's largest manufacturers of anti-TB, cephalosporins and cardiovascular drugs. Dominant market share in rifampicin, ethambutol and
pyrazinamide
-
Developed world's first once-a-day tablet for
cephalexin
-
India's first pharmaceutical company to be granted an
exclusive license by the innovator for marketing a branded finished product Suprax (generic cefixime) in the
US
